New Zealand markets closed
  • NZX 50

    10,958.81
    -59.79 (-0.54%)
     
  • NZD/USD

    0.6245
    +0.0006 (+0.09%)
     
  • ALL ORDS

    6,877.90
    -75.50 (-1.09%)
     
  • OIL

    111.63
    -0.13 (-0.12%)
     
  • GOLD

    1,817.20
    -4.00 (-0.22%)
     

Krystal Biotech to Participate in Bank of America Merrill Lynch Global Healthcare Conference

·1-min read
Krystal Biotech, Inc.
Krystal Biotech, Inc.

PITTSBURGH, May 03, 2022 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc., (the “Company”) (NASDAQ: KRYS), the leader in redosable gene therapy, today announced that Krish S. Krishnan, Chairman and Chief Executive Officer, will participate in the Bank of America Merrill Lynch Global Healthcare Conference.

Details for the event are as follows:

Bank of America Merrill Lynch Global Healthcare Conference

Date:

Tuesday, May 10, 2022

Time:

9:20am PDT

Webcast Link:

https://bofa.veracast.com/webcasts/bofa/hc2022/id6InQpA.cfm


A webcast of the presentation will be available on the Investors section of the Company’s website for 90 days following the presentation.

About Krystal Biotech

Krystal Biotech, Inc. (NASDAQ: KRYS) is a pivotal-stage gene therapy company leveraging its proprietary, redosable gene therapy platform and in-house manufacturing capabilities to develop life-changing treatment options for patients with serious diseases, including rare diseases in skin, lung, and other areas. For more information, please visit http://www.krystalbio.com and follow @KrystalBiotech on LinkedIn and Twitter.

CONTACT:

Investors and Media:
Meg Dodge
Krystal Biotech
mdodge@krystalbio.com

Source: Krystal Biotech, Inc.


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting